Search Immortality Topics:

Page 11234..1020..»


Category Archives: Nanotechnology

Chiral powers next-generation electronics with nanomaterials as it raises $3.8m – Installation – Installation and AV Technology Europe

Nanotechnology companyChiral has announced a $3.8m funding round to address the challenge of silicon-based chip shortages, innovating the way nanomaterials are integrated into devices. Its expertise in nanotechnology, automation, and high-precision robotics is said to be pivotal in the industrys move beyond silicon to the next generation of electronics. The pre-seed funding round was co-led by Founderful (formerly Wingman Ventures) and HCVC and includes grants from ETH Zurich and Venture Kick.

Chipmaking has become one of the worlds most critical technologies in the last two decades. The main driver of this explosive growth has been the continuous scaling of silicon technology (widely known as Moores Law). But these advances in silicon technology are slowing down, as we reach the physical limits of silicon. For this reason, the industry has been investing heavily in nanomaterials like carbon nanotube, graphene and TMDs, which are expected to enable chips with unprecedented functionality. However, making electronic devices with these extremely small materials at speed, with precision, and without compromising on quality has been a long-standing obstacle.

Research has evidenced the use case and impact of nanomaterials across a range of electronics including high-performance transistors, low-power sensors, quantum devices, and many more. However, existing production methods, mostly based on chemistry, are not controllable, which has thus far prevented commercialisation of these devices.

Chiral has built high-speed, automated, robotic machines that integrate nanomaterials into devices. These machines can robotically place micrometer-sized (or even nanometer-sized) materials on small chips. Repeating these motions in a fast and automated manner requires a very high level of engineering, which, when done right, ensures the precision and control that conventional chemistry-based methods lack.

The development of Chirals technology started as a national research project conducted at the Swiss Federal Institutes of Technology (ETH Zurich, EPFL, and Empa), in which the companys co-founders, Seoho Jung, Natanael Lanz, and Andre Butzerin participated as PhD students. After 4 years of R&D, the research team finished its first prototype machine, which was 100 times faster than the other systems available at the time. The immediate reaction of the market to the prototype, which quickly led to the companys first batch of pilot customers, convinced the co-founders that they should continue their activity as a company. They incorporated Chiral in June 2023 as a result.

At Chiral, we are pioneering the next generation of electronic devices across industry, explained Seoho Jung, co-founder and CEO at Chiral. Chipmakers are aware of the potential of nanomaterials and were bringing that potential to life. This funding will accelerate the development of our next machine, which will unlock new market opportunities with its versatility and performance. We are also excited to scale our team to keep up with the growing demand and customer base.

The global nanotechnology market size is projected to grow from $79.14 billion in 2023 to $248.56 billion by 2030, at a CAGR of 17.8% (Fortune business insights research). One of the largest chipmakers in the world, Taiwan Semiconductor Manufacturing Company (TSMC)presented its development roadmapshowing nanomaterial-based transistors as its future architecture.

Were thrilled to join forces with Chiral alongside HCVC, said Pascal Mathis, founding partner at Founderful. Chirals AI- and robotics-based technology lets us envision a future where nanomaterial-based chips are being produced at the scale needed for commercialisation a major bottleneck up until now. We look forward to supporting Seoho, Natanael and Andr in their journey to introduce a new paradigm of chips beyond silicon.

Alexis Houssou, founding partner at HCVC, added:With the current boom in AI applications, we stand at a pivotal moment where the slowdown of Moores law threatens to decelerate the pace of technological progress significantly. The team at Chiral has embarked on a critical mission to pave the way toward a groundbreaking post-silicon era, promising to transcend current limitations and unlock new possibilities for advancement. We couldnt be more excited to support their mission, in collaboration with Founderful, as they build the future of computing infrastructure.

Jung concluded:In the future, it will be normal for electronic devices or chips to contain nanomaterials. The development roadmaps of the worlds leading chipmakers like TSMC, Samsung, and Intel all share our vision. We are confident that Chiral technology will empower the industry to make this transition faster.

See the rest here:
Chiral powers next-generation electronics with nanomaterials as it raises $3.8m - Installation - Installation and AV Technology Europe

Posted in Nanotechnology | Comments Off on Chiral powers next-generation electronics with nanomaterials as it raises $3.8m – Installation – Installation and AV Technology Europe

Global Dermatological Drugs Market Set to Surpass US$30 Billion with Advanced Nanotechnology and Aging … – PR Newswire

DUBLIN, Feb. 28, 2024 /PRNewswire/ -- The "Dermatological Drugs Market Report 2024-2034" has been added to ResearchAndMarkets.com's offering.

World revenue for Dermatological Drugs Market, in terms of value is forecast to surpass US$30 billion in 2024, with strong revenue growth through to 2034.

Geriatric Population Driving Demand for Dermatological Drugs

As the global population ages at an unprecedented pace, the dermatological drugs market is poised for a significant upswing. According to the World Health Organization (WHO), by 2050, 80% of older individuals will reside in low- and middle-income countries. The rapid acceleration in population aging, outpacing historical trends, is a key catalyst. As per WHO, by 2030, one in every 6 person will be aged 60 or over. Also, from 2021 to 2050, population aged over 65 in Asia will grow by more than half-a-billion, creating a burgeoning market for dermatological drugs. This demographic shift signifies an increased demand for skincare solutions tailored to age-related dermatological concerns, such as wrinkles, age spots, and skin conditions prevalent in the elderly. Thus, the coming years will mark a lucrative era for the dermatological drugs industry, driven by the unique needs of the expanding geriatric population.

Nanotechnology in Drug Delivery Could Revolutionize the Dermatological Drugs Market

In the dynamic landscape of dermatology, the integration of cutting-edge technological advancements in drug delivery is poised to propel the market to unprecedented heights. The advent of nanotechnology enables precise targeting of skin cells, enhancing the efficacy of dermatological drugs while minimizing side effects. This revolutionary approach ensures a more tailored and efficient treatment, boosting patient outcomes and satisfaction. Micro-needle technology is reshaping the administration of dermatological drugs. These minimally invasive devices painlessly penetrate the skin, facilitating controlled and sustained release of therapeutic agents. This not only improves patient compliance but also optimizes drug absorption, leading to quicker and more effective results. Several companies are actively researching and developing nanocarriers and smart delivery systems for skincare applications such as NanoVibronix (US) and Nanologica (Sweden).

Furthermore, the incorporation of smart polymers in drug formulations represents a paradigm shift in dermatological treatments. These polymers respond to specific physiological cues, releasing drugs at the right time and in the right amounts. This precision enhances therapeutic outcomes, reduces the frequency of application, and minimizes adverse reactions.

Forecasts to 2034 and other analyses reveal commercial prospects

Segments Covered in the Report

Route of Administration

Disease

Prescription Mode

Distribution Channel

In addition to the revenue predictions for the overall world market and segments, you will also find revenue forecasts for five regional and 21 leading national markets.

The report also includes profiles and for some of the leading companies in the Dermatological Drugs Market, 2024 to 2034, with a focus on this segment of these companies' operations.

Leading companies profiled in the report

In summary, the report provides you with the following knowledge:

Key Topics Covered:

1 Report Overview

2 Executive Summary

3 Market Overview 3.1 Key Findings 3.2 Market Dynamics 3.2.1 Market Driving Factors 3.2.1.1 Increasing Prevalence of Skin Disorders 3.2.1.2 Growing Awareness and Patient Education 3.2.1.3 Globalization and Urbanization 3.2.1.4 Revolutionizing Dermatology: Unleashing Market Growth Through Advanced Drug Delivery Technologies 3.2.1.5 Innovative Breakthroughs: Propelling Dermatological Drugs Market Through Surging R&D Investments 3.2.1.6 Geriatric Population Driving Dermatological Drugs Market 3.2.2 Market Restraining Factors 3.2.2.1 Generic Competition 3.2.2.2 Adverse Effects and Safety Concerns 3.2.2.3 Drug Resistance 3.2.2.4 Non-Pharmacological Options: A Hindrance to Dermatological Drugs Market Growth 3.2.2.5 Limited Reimbursement and Coverage Challenges in Dermatological Drugs Sector 3.2.2.6 Regulatory Approval Process Poses Barriers to Dermatological Drugs Market Growth 3.2.3 Market Opportunities 3.2.3.1 Approval of Novel Dermatological Drugs 3.2.3.2 Advancements in Dermatology Research and Technology 3.2.3.3 Telemedicine and E-Health 3.3 COVID-19 Impact Analysis 3.4 Porter's Five Forces Analysis 3.5 PEST Analysis

4 Dermatological Drugs Market Analysis by Route of Administration

5 Dermatological Drugs Market Analysis by Disease

6 Dermatological Drugs Market Analysis by Prescription Mode

7 Dermatological Drugs market Analysis by Distribution Channel

8 Dermatological Drugs Market Analysis by Region

9 North America Dermatological Drugs Market Analysis

10 Europe Dermatological Drugs Market Analysis

11 Asia Pacific Dermatological Drugs Market Analysis

12 Latin America Dermatological Drugs Market Analysis

13 MEA Dermatological Drugs market Analysis

14 Company Profiles

For more information about this report visit https://www.researchandmarkets.com/r/icaouj

About ResearchAndMarkets.com ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Media Contact:

Research and Markets Laura Wood, Senior Manager [emailprotected] For E.S.T Office Hours Call +1-917-300-0470 For U.S./CAN Toll Free Call +1-800-526-8630 For GMT Office Hours Call +353-1-416-8900 U.S. Fax: 646-607-1907 Fax (outside U.S.): +353-1-481-1716

Logo: https://mma.prnewswire.com/media/539438/Research_and_Markets_Logo.jpg

SOURCE Research and Markets

Read more:
Global Dermatological Drugs Market Set to Surpass US$30 Billion with Advanced Nanotechnology and Aging ... - PR Newswire

Posted in Nanotechnology | Comments Off on Global Dermatological Drugs Market Set to Surpass US$30 Billion with Advanced Nanotechnology and Aging … – PR Newswire

Iran, a pioneer in nanotechnology – Press TV

Iran has made nanotechnology a priority in recent years, achieving remarkable success. The nanotechnology research website StatNano has ranked Iran as fourth in the world in nanotechnology publications.

The number of scientific articles is deemed a significant parameter for measuring and comparing scientific development, according to StatNano that provides the global and regional ranking of the main indicators of nano science, technology, and industry. China was atop the rankings, followed by the United States and India.

International entities have acknowledged Iranian contributions to the field. In February 2022, the American Institute of Physics published a scholarly article on the use of nanomaterials for cancer treatment by Iranian scientists.

Among Iran's nanotechnology products, 42% are related to construction, 17% to petroleum and 13% to automobile manufacturing.

Nanotechnology refers to industrial production from atomic and molecule-sized matter. It leverages the properties of nanoparticles into a wide range of applications spanning a vast number of industries. Key accomplishments in the field of nanotechnology can be seen across a wide variety of engineering, energy and medical sectors.

The field is important because it is changing the world. It is a broad discipline that includes diverse scientific fields such as surface science, molecular biology, molecular engineering, organic chemistry, energy storage, and semiconductor physics.

Many experts believe that nanotechnology will bring about a new era of productivity and wealth, and this is reflected in the growth in public investment in technologies and research over the past two decades.

Nanotechnology has become one of the pillars of modern scientific research. The evolution of nano-based products and nanomaterials in the past few years has immensely benefited the entire economy and society.

Over the last two decades, the world has observed a steady increase in the number of industries producing nano-based products and the number of countries promoting nanotechnology. There is a continuous increase in the number of patents registered under nanotechnology worldwide. More importantly, the ratio of nanotechnology to nominal GDP has increased significantly, suggesting that the contribution of nanotechnology to World GDP has increased. Nanotechnology has also played a key role in new job creation.

Many developing nations such as Brazil, India, the Philippines, Chile, Mexico, and South Africa are emerging as frontrunners in nanotechnology research. Iran is a success story, having established government-funded programs and research institutes to push the envelope of nanotechnology.

The Islamic Republic initiated its national nanotechnology development plan referred to as "Future Strategy" in 2005, after being advised by several scholars about the impact of that the technology could have on its wealth and economy.

State planners decided that developing nanotechnology could help Iran address its chronic economic woes resulting from US sanctions and mismanagement.

Nanotechnology can help Iran renovate the industries which are using old technologies and make them competitive. The field is also best placed to halt the migration of professionals from the country. High efciency, convenience, and the low price of nanotechnology products can boost demand and create a high level of satisfaction. Nanotechnology is also crucial to sustainable economic development.

Over the past few years, doctoral courses related to nanotechnology have been established in 23 Iranian universities in such fields as nanochemistry, nanophysics, nanomaterials and nanomedicine. Also, 66 universities accept students for the master's degree program.

More here:
Iran, a pioneer in nanotechnology - Press TV

Posted in Nanotechnology | Comments Off on Iran, a pioneer in nanotechnology – Press TV

Chinese scientists develop powerful hydrogen therapy that could reverse ageing – South China Morning Post

Using nanotechnology, the team has developed a scaffold implant that delivers hydrogen 40,000 times more efficiently than other methods such as drinking hydrogen-rich water or inhaling hydrogen gas.

According to the paper, the implant can deliver a slow and sustained release of hydrogen for up to a week, compared to the 30-minute limit on hydrogen-rich water. The study found the prolonged treatment helped repair bone defects in older mice.

37:19

Chinas elderly are heading to retirement, heres why thats a problem

Chinas elderly are heading to retirement, heres why thats a problem

Hydrogen acts as an anti-inflammatory agent with the ability to scavenge the toxic radicals associated with ageing.

It has been found to have a universal anti-senescence impact on various cells and tissues, meaning that it helps them continue to replicate and grow.

Corresponding author He Qianjun, from Shanghai Jiao Tong University, told the South China Morning Post the scaffold was developed to repair bone defects in the elderly, but could one day be used for other age-related conditions and diseases, including Alzheimers.

We developed [the method] mainly based on our discovery of the broad-spectrum anti-ageing properties of hydrogen, He said, in an email to the Post.

Chinese nanoplatform aircraft carrier delivers drugs to cancer patients

The scaffold had a significant effect in inducing bone growth compared to the blank scaffold that does not produce hydrogen, He said.

Senescence the gradual deterioration of bodily function as we age is one of the major causes of age-related conditions and diseases. In recent years, links have also been identified between cellular senescence and these conditions.

At a cellular level, senescence can be responsible for DNA damage and the loss of cell cycle functions like division and growth.

Cells can also secrete materials that cause inflammation, creating a senescence micro-environment that causes tissues and bones to decline in their ability to self-repair, according to the paper.

This persistent inflammation and loss of regenerative ability is a main obstacle to effective tissue repair for elderly people, the researchers said.

Existing anti-senescence treatments are unable to universally regulate the entire micro-environment, the paper said.

But the researchers found that hydrogen is able to alter the senescence micro-environment from pro-inflammation to anti-inflammation, supporting bone defect regeneration.

According to He, the hydrogen is able to remodel the senescence micro-environment during the early stage of inflammation and have a continuing effect on later bone repair.

Chinese scientists find a way to restore bodys cancer-fighting cells

The implantable scaffold is biosafe, using products like metasilicate and calcium ions as well as hydrogen gas, he said.

The researchers created the scaffold with calcium disilicide nanoparticles hydrolysed to store hydrogen sprayed on to porous, bioactive glass and wrapped in a biodegradable polymer to stop it degrading and releasing the hydrogen too quickly.

The device was tested on 24-month-old mice equivalent to 70 in humans that had femoral bone defects.

The scaffold was able to release hydrogen for seven to nine days, a duration not reported for any other method, the paper said.

Hong Kong university builds case for using antidiabetic drug for anti-ageing

The teams next challenge is to create a scaffold with an even longer period of release a development that could be even better for repair, according to He.

While more research is needed, further development of high-performance materials to deliver hydrogen is crucial.

We believe that continuous hydrogen supply will be a universal anti-ageing technology that can treat various ageing-related diseases, including preventing and treating diseases like Alzheimers, He said.

Follow this link:
Chinese scientists develop powerful hydrogen therapy that could reverse ageing - South China Morning Post

Posted in Nanotechnology | Comments Off on Chinese scientists develop powerful hydrogen therapy that could reverse ageing – South China Morning Post

Ten Years of the Singh Center for Nanotechnology – University of Pennsylvania

Ten Years of the Singh Center for Nanotechnology

2023 marks the 10th anniversary of the Singh Center for Nanotechnology, a building that exemplifies cutting-edge scientific research by virtue of its sleek geometry and meticulous attention to detail by all those involved in its development.

Heralded by many as an architectural gem, not only at the University of Pennsylvania but in Philadelphia. The iconic, glass-clad, cantilevered 78,000 square-foot structure is nestled between the Laboratory for Research on the Structure of Matter and David Rittenhouse Laboratory on the eastern edge of campus. It was also Penns first collaborative building between two schools: the School of Engineering and Applied Science and the School of Arts & Sciences.

Over the last decade, the center has opened its doors to students, academics, industry professionals, and many more who seek out the facilitys state-of-the-art equipment geared at serving two high-precision objectives: to build and measure.

Function Guiding Form: The Planning Phase

Eduardo Glandt, emeritus dean of Penn Engineering, played a crucial role in establishing the iconic structure. He jokes that he was quite literally at the ground floor of the $93 million-dollar centers construction, as he led the charge in securing funding, scouting faculty and staff members, and meeting with architects to make the dream a reality. Dr. Glandt recalls that finding the right architects was no small feat, saying, The demands on the designers were steep. So, we were in contact with about 10 different firms, and we had to go to Helsinki, Tokyo, and Basel to find the right people who were up for the challenge.

Ultimately, the firm suited to the task was closer to home than expected: Weiss/Manfredi, a firm co-founded by Marion Weiss, the Graham Professor of Practice in Architecture at Penns Weitzman School of Design.

Dr. Glandt explains that the Singh Centers design, with its distinctive U-shaped floor plan, was born out of necessity, as it needed to be seamlessly integrated around the pre-existing Edison Building. Later, the Edison Building, once an integral part of the Singh Center complex, would be razed and the land turned into a garden, adding yet another layer of serenity to the landscape.

Another set of significant constraints the architects faced was that the internal environment needed to be pristine: free from vibrations to accommodate an electron microscope in the characterization facility and absent from certain ultraviolet light used in the fabrication room. The latter resulted in another unique identifier, namely, the buildings marigold dcor.

Dr. Glandt notes that the glass that separates the common areas from the photolithographic activities, which is essentially using light to transfer patterns to materials, is amber to prevent UV contamination. The architects ran with this constraint and used it as a motif for the interior, said Dr. Glandt. Its incredible to see what they were able to do, and how thats given the building such a distinct look.

Dr. Glandt also expresses admiration for the buildings aesthetic and believes it is part and parcel of the centers success over the years.

Beauty tends to attract beauty, and I think the centers emblematic of this in many ways, he said. Before opening, Dr. Glandt and others worked hard to resurface Tony Smiths We Lost, a famed sculpture that used to sit on College Green, because they knew its cubic geometry would greatly complement the centers.

Following this, members of the community reached out, suggesting and offering more artworks to be showcased in the center, one of which includes some of the first microscopy artistic photographs. This set of photos can be seen at the entrance of the electron microscopy facility. Dr. Glandt also notes that the architects added We Lost to their renderings and recalls that when he presented the plans to scientific director Mark Allen during his recruitment, Dr. Allen marveled at the notion of art at a fabrication lab.

A Hub for Innovation

Dr. Allen said he has witnessed the centers facilities play an important role in a multitude of projects over the last 10 years. From pioneering drug delivery mechanisms targeting cancerous cells on a molecular scale to formulating energy-efficient batteries and next-generation semiconductors, the centers multidisciplinary approach has been a strength, enabling researchers from varying disciplines to come together in one space. Although the Singh Center was initially a joint venture between Penn Engineering and Arts & Sciences, scientific director Mark Allen said it has also proven useful to researchers from the Perelman School of Medicine, Weitzman School of Design, and schools of Dental Medicine and Veterinary Medicine.

Its quite a nexus of collaboration, which I believe is the essence of innovation, said Dr. Allen, who is also the Alfred Fitler Moore Professor in Penn Engineering. Our ethos revolves around converging varied fields of study, pushing the boundaries of whats conceivable, and fortunately, we see that happen at an exciting time for nanotechnology.

In reflecting on the centers growth and what continues to draw people in, Dr. Allen said, the efforts by the deans involved have been tremendously helpful in allowing us to achieve our science goals.

Dr. Allen praises the current deans, Vijay Kumar of Engineering and Steven J. Fluharty of Arts & Sciences, for picking up the mantle in expanding the centers capabilities through supporting initiatives for hiring faculty with diverse backgrounds in the nanoworld.

The Singh Center has driven revolutionary advancements at the nano- and microscale- across many applications, said Dean Kumar. This includes novel micro-electromechanical systems, the invention of new catalysts and storage technologies to combat climate change, and the development of new biomaterials and drug delivery systems for health care.

Dean Fluharty, who is also the Thomas S. Gates, Jr. Professor of Psychology, Pharmacology, and Neuroscience, added that the center embodies a spirit of collaboration that over the past decade has paved the way for significant advancements in a wide range of research areas.

One of our research teams harnessed the centers state-of-the-art tools and materials to develop a new drug delivery device that can transport microparticles against cardiovascular flows, and another group created patterned photoelectrodes that use sunlight to convert carbon dioxide to energy-dense chemical fueland these are just two examples of the innovative work we are seeing, he said. I look forward to many more exciting discoveries in the years to come.

Gerald Lopez, the Singh Centers associate director and director of business operations, adds that under Dr. Allens leadership, the facility has been at the forefront of research, boasting more than 1,000 scientific publications, enabling more than 200 work years, and has been crowned the Mid-Atlantic Nanotechnology Hub.

Helping to Shape the Nanotech Future

Dr. Allen notes that it has been an exciting time for nanotechnology these last few years, citing the 2022 CHIPS and Science Act as recognition of the impact this field has on many spheres of modern life and science. More recently, how the 2023 Nobel Prize in Chemistry was awarded to researchers who pioneered a method to use nanocrystals for a range of activities related to light transmission.

Dr. Allen explained that the center has also inspired the next generation of nanotech practitioners by lowering the barrier of entry to some of the most sophisticated machining tools in this space.

The center has really become a testbed that welcomes people with ideas. We provide an environment that teaches and fosters practices that challenge those ideas and potentially use that information to build something, he said. We will continuously partner with other institutions in and around Philly, like the Community College of Philadelphia, to give more students hands-on experience with the cutting-edge tools that will transform the future.

This is an especially meaningful partnership since Dr. Allen noted that the employment workforce in many large semiconductor fabrication places is highly diverse.

Its roughly 50% bachelors level engineers, which is usually the technical staff, maybe 25% graduate degrees, and the other quarter, people with either no college or associates degrees because there is a need at all levels. Dr. Allen said. So, if were going to have an effective workforce development activity, we need to engage at all levels. And I think thats one of the wonderful things being done at places like the Singh Center.

Looking forward, Drs. Glandt and Allen are filled with anticipation. Nanotechnologys role in our daily lives is burgeoning, Dr. Allen said. The Singh Center, with its unparalleled infrastructure and dynamic research community, is geared to spearhead this transformation and were excited to see whats next and to keep sharing what we have coming down the pike.

Adapted from a Penn Today article written by Nathi Magubane, November 20, 2023.

Read more from the original source:
Ten Years of the Singh Center for Nanotechnology - University of Pennsylvania

Posted in Nanotechnology | Comments Off on Ten Years of the Singh Center for Nanotechnology – University of Pennsylvania

AI and Nanotechnology: A Revolutionary Synergy in Healthcare – Medriva

With the rapid advancements in technology, the healthcare industry is on the verge of a paradigm shift. The promising union of Artificial Intelligence (AI) and nanotechnology is opening up a world of possibilities in medical treatments. This transformative synergy can revolutionize healthcare by emulating human intelligence, performing complex tasks, and manipulating matter at atomic and molecular levels with precision. However, while the potential is vast, the actualization of AI-nanobots in healthcare is still on the horizon.

AIs role in healthcare is already significant with its capability to quickly interpret data, find patterns, and make predictions to support medical decision making. An example of this can be seen in India, where radiologists are using deep learning algorithms to automate image processing, interpretation, and report generation. One groundbreaking application is the screening of diabetic retinopathy (DR) by eliminating the need for pupil dilation and using AI to detect the presence of DR in retinal photographs. This use of AI significantly reduces screening time and improves early detection of DR.

On the other hand, nanotechnology is paving the way for significant breakthroughs in medicine. With the ability to control and manipulate matter at an atomic and molecular level, nanotechnology brings unprecedented precision to medical treatments. For instance, DNA robots are currently being tested in animals to seek out and destroy cancer cells, demonstrating the potential of nanobots in healthcare.

It is predicted that by 2030, nanobots will be flowing through human bloodstreams, bringing a host of potential applications in healthcare. These range from treating cancer and conducting cell research, to delivering drugs with a high degree of accuracy, reducing plaque in veins, and addressing dietary issues. Furthermore, nanobots could constantly monitor our bodies for maladies and transmit this information to a cloud for close monitoring by medical staff, leading to a greater state of connectivity and proactive healthcare.

Despite the promising potential, the application of AI-nanobots in healthcare presents certain challenges. One of these is the issue of delivering drugs to specific target tissues and cells in the brain. A study using predictive models based on large datasets suggests that factors such as the release rate and molecular weight have a negative impact on brain targeting. Nevertheless, the study also found a slightly positive impact on brain targeting when the drug is a P-glycoprotein substrate, indicating potential pathways for overcoming these challenges.

Moreover, while the idea of nanobots transmitting our thoughts to the cloud is intriguing, it is still a far-fetched concept. As we move forward, it is crucial to approach these developments with curiosity and responsibility, fostering progress while navigating the ethical and practical implications of these technologies.

In conclusion, the future of healthcare is bright with the promising potential of AI-nanobots. While we are still on the cusp of this technological revolution, the journey towards it is filled with exciting possibilities and challenges. As we continue to explore and innovate, the synergy of AI and nanotechnology holds the promise of a transformative impact on healthcare.

Link:
AI and Nanotechnology: A Revolutionary Synergy in Healthcare - Medriva

Posted in Nanotechnology | Comments Off on AI and Nanotechnology: A Revolutionary Synergy in Healthcare – Medriva